61
2024-02-13 09:00:04
On December 15, 2023, the European Medicines Agency (EMA) approved the first treatment using Crispr genome modification technology. This medical advance aims to cut out a DNA sequence and replace it with another, using a pair of “molecular scissors”. The first treatment using this method should be to relieve patients suffering from sickle cell anemia or beta thalassemia, two genetic hemoglobin diseases.
#expect #Crispr #technology #gene #therapy